Stephen Feldman was diagnosed with chronic lymphocytic leukemia (CLL) in 2014 and began a one-year treatment in 2017 with a combination of ibrutinib and obinutuzumab, culminating in a complete remission (MRD undetectable). Mr. Feldman is the facilitator for the CLL Society’s City of Hope Hospital support group.
He earned his bachelor's degree in biology from Hunter College in New York and a master's degree in education and counseling psychology from Fordham University in New York.
